Biology Reference
In-Depth Information
Tenor H, Hatzelmann A, Church MK, Schudt C, Shute JK (1996) Effects of theophylline and
rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from
normal and atopic subjects. Br J Pharmacol 118:1727-1735
Tenor H, Burgbacher B, Schudt C, Hatzelmann A (2005) Effects of roflumilast and other PDE4
inhibitors on human CD8+ T-cell functions. Eur Respir J Suppl 26:717s
Tenor H, Bundschuh D, Schudt C, Bredenbr
oker D, Hatzelmann A (2007) Phosphodiesterase
4 inhibitors in the treatment of COPD. In: Stockley RS, Renard SI, Rabe KF, Celli B (eds)
Chronic obstructive pulmonary disease. Blackwell, Oxford
Thompson WJ, Appleman MM (1971) Multiple cyclic nucleotide phosphodiesterase activities
from rat brain. Biochemistry 10:311-316
Thompson WJ, Ross CP, Pledger WJ, Strada SJ, Banner RL, Hersh EM (1976) Cyclic adenosine
3
0
:5
0
-monophosphate phosphodiesterase: distinct forms in human lymphocytes and monocytes.
J Biol Chem 251:4922-4929
Thompson WJ, Terasaki WL, Epstein PM, Strada SJ (1979) Assay of cyclic nucleotide phospho-
diesterase and resolution of multiple molecular forms of the enzyme. Adv Cyclic Nucl Res
10:69-92
Thorne JR, Broadley KJ (1994) Adenosine-induced bronchoconstriction in conscious hyperre-
sponsive and sensitized guinea-pigs. Am J Respir Crit Care Med 149:392-399
Thusu KJ, Morin FC, Russell JA, Steinhorn RA (1995) The cGMP phosphodiesterase inhibitor
zaprinast enhances the efffect of nitric oxide. Am J Respir Crit Care Med 152:1605-1610
Togo S, Liu X, Wang X, Sugiura H, Kamio K, Kawasaki S, Kobayashi T, Ertl RF, Ahn Y, Holz O,
Magnussen H, Fredriksson K, Skold CM, Rennard SI (2009) The PDE4 inhibitors roflumilast
and rolipran augment PGE2 inhibition of TGFß1 stimulated fibroblasts. Am J Physiol Lung
Cell Mol Physiol 296:L959-L969
Tomkinson A, Karlsson J-A, Raeburn D (1993) Comparison of the effects of selective inhibitors of
phosphodiesterase type III an IV in airway smooth muscle with differing ß-adrenoceptor
subtypes. Br J Pharmacol 108:57-61
Torphy TJ, Cieslinsky LB (1989) Characterization and selective Inhibition of cyclic nucleotide
phosphodiesterase isoenzymes in canine tracheal smooth muscle. Mol Pharmacol 37:206-214
Torphy TJ, Undem BJ (1991) Phosphodiesterase inhibitors: new opportunities for treatment of
asthma. Thorax 46:512-523
Torphy TJ, Burman M, Huang LB, Tucker SS (1988) Inhibition of the low Km cyclic AMP
phosphodiesterase in intact canine trachealis by SKF 94863: mechanical and biochemical
responses. J Pharmacol Exp Ther 246:843-850
Torphy TJ, Zhou HL, Cieslinski LB (1992a) Stimulation of beta adrenoceptors in a human
monocyte cell line (U937) up-regulatis cyclic AMP-specific phosphodiesterase activity.
J Pharmacol Exp Ther 263:1195-1205
Torphy TJ, Stadel JM, Burman M, Cieslinski LB, McLaughlin MM, With JR, Livi GP (1992b)
Coexpression of human cAMP-specific phosphodiesterase activity and high affinity rolipram
binding in yeast. J Biol Chem 267:1796-1804
Torphy TJ, Undem BJ, Cieslinski LB, Luttmann MA, Reeves ML, Hay DW (1993) Identification,
characterization and functional role of phosphodiesterase isozymes in human airway smooth
muscle. J Pharmacol Exp Ther 265:1213-1223
Trendelenburg O (1912) Physiologische und pharmakologische Untersuchungen an der isolierten
Bronchialmuskulatur. Arch Exp Path Pharmacol 69:79-107
Tudor RM, Voelkel NF (2002) The pathobiology of chronic bronchitis and emphysema. In:
Voelkel NF, MacNee W (eds) Chronic obstructive lung disease. BC Decker, London
Underwood DC, Osborn RR, Novak LB, Matthews JK, Newsholme SJ, Undem BJ, Hand JM,
Torphy TJ (1993) Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration
in the guinea pig by the cAMP-specific phosphodiesterase inhibitor rolipram. J Pharmacol Exp
Ther 266:306-313
Underwood DC, Kotzer CJ, Bochnovicz S, Osborn RR, Luttmann MA, Hay DWP,
Torphy TJ (1994) Comparison of Phosphodiesterase III, IV and dual III/IV inhibitors on
€
